羟氯喹全球市场规模、份额、成长分析、最终用户、分销管道 - 2024-2031 年产业预测

2022年羟氯喹的全球市场规模将达到9,500亿美元，从2023年的1兆美元成长到2031年的1.53兆美元，预测期间（2024-2031年）复合年增长率为5.40%，预计还将增长。

该市场旨在为患有这些疾病的患者提供有效的治疗解决方案，以缓解症状、控制疾病并提高生活品质。羟氯喹市场的主要驱动力之一是疟疾、类风湿性关节炎和狼疮等疾病的流行，这些疾病影响着世界上很大一部分人口，因此需要广泛使用羟氯喹作为治疗方法。此外，老年人口的不断增长和自体免疫疾病的增加也导致对羟氯喹的需求增加。但市面上也存在多种阻碍因素。对与羟氯喹相关的安全性和潜在副作用（例如视网膜毒性和心律不整）的担忧促使医疗保健专业人员和患者保持谨慎。此外，有关羟氯喹使用的监管限制和指南，特别是仿单标示外处方情况对市场扩张构成了挑战。羟氯喹市场也面临一些障碍，例如替代治疗方案的可用性以及疟疾高发生率地区出现抗药性。儘管如此，全球羟氯喹市场的一个重要目的是为患有疟疾、类风湿性关节炎、红斑性狼疮和其他自体免疫疾病的人提供有效的治疗选择。儘管面临挑战，但正在进行的研究、临床试验和合作仍有充足的机会，有可能推动羟氯喹市场的成长和发展。

目录

执行摘要

• 市场概况
• 命运之轮

调查方法

• 资讯采购
• 次要和主要资料来源
• 市场规模估算
• 市场假设与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管环境
• 波特的分析
• 对未来中断的特殊考虑

羟氯喹全球市场：按最终用户分类

• 市场概况
• 医院
• 专科诊所
• 居家护理
• 其他的

羟氯喹全球市场：按通路

• 市场概况
• 医院药房
• 零售药房
• 网路药房
• 其他的

羟氯喹的全球市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2021年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2021年）

主要企业简介

• Sanofi（France）
• Novartis（Switzerland）
• Aurobindo Pharma（India）
• Dr. Reddy's Laboratories（India）
• Sun Pharmaceutical Industries（India）
• Cipla（India）
• Teva Pharmaceuticals（Israel）
• Hikma Pharmaceuticals（UK）
• Sandoz（Switzerland）
• Mylan（US）
• Apotex（Canada）
• Ranbaxy Laboratories（India）
• Torrent Pharmaceuticals（India）
• Lupin Pharmaceuticals（India）
• Zydus Cadila（India）
• Aurobindo Pharma USA（US）
• Novartis Pharmaceuticals Corporation（US）
• Sun Pharmaceutical Industries USA（US）
• Hikma Pharmaceuticals USA（US）
• Sandoz Inc.（US）

Global hydroxychloroquine market size was valued at USD 0.95 trillion in 2022 and is poised to grow from USD 1.00 trillion in 2023 to USD 1.53 trillion by 2031, at a CAGR of 5.40% during the forecast period (2024-2031).

The objective of the market is to offer an efficient therapeutic solution for patients grappling with these ailments, providing symptom relief, disease management, and enhanced quality of life. One of the primary driving forces behind the hydroxychloroquine market is the prevalence of diseases like malaria, rheumatoid arthritis, and lupus, which affect a substantial portion of the global population, necessitating widespread utilization of hydroxychloroquine as a treatment approach. Furthermore, the increasing elderly population and the consequent rise in autoimmune disorders contribute to the growing demand for hydroxychloroquine. However, the market encounters various restraining factors. Concerns regarding safety and potential side effects linked to hydroxychloroquine, such as retinal toxicity and cardiac arrhythmias, have prompted caution among healthcare practitioners and patients alike. Additionally, regulatory constraints and guidelines concerning hydroxychloroquine usage, particularly in off-label prescribing scenarios, pose challenges to market expansion. The hydroxychloroquine market also confronts hurdles such as the availability of alternative treatment options and the emergence of drug resistance in malaria-prone regions. Nevertheless, the global hydroxychloroquine market serves the crucial purpose of delivering effective treatment choices for individuals with malaria, rheumatoid arthritis, lupus, and other autoimmune disorders. Despite the challenges, opportunities abound in ongoing research, clinical trials, and collaborations, which have the potential to drive growth and advancement within the hydroxychloroquine market.

Top-down and bottom-up approaches were used to estimate and validate the size of the global hydroxychloroquine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hydroxychloroquine Market Segmental Analysis

The global hydroxychloroquine market is segmented based on end-user, distribution channel, and region. By end-user, the market is segmented into hospitals, specialty clinics, homecare, and others. By distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Hydroxychloroquine Market

The global demand for hydroxychloroquine as a treatment for malaria remained a significant driver of market growth. Malaria is a widespread infectious disease, particularly prevalent in regions like Sub-Saharan Africa and Southeast Asia. Hydroxychloroquine has long been recognized as an effective antimalarial medication, contributing to its widespread usage. The continued efforts to combat malaria and the persistent need for effective treatment options further fueled the demand for hydroxychloroquine in 2022.

Restraints in the Global Hydroxychloroquine Market

The hydroxychloroquine market encountered a notable challenge stemming from safety concerns and regulatory restrictions linked to its usage. Various studies and reports spotlighting potential side effects, such as retinal toxicity and cardiac arrhythmias, prompted caution among healthcare professionals and regulatory bodies. Consequently, restrictions were imposed on the off-label utilization of hydroxychloroquine, accompanied by heightened scrutiny of its safety profile.

Market Trends of the Global Hydroxychloroquine Market

A noteworthy trend observed in the hydroxychloroquine market was the investigation of combination therapies. Researchers and healthcare professionals delved into the potential synergies of hydroxychloroquine when paired with other medications or treatment approaches. The objective was to improve treatment outcomes, mitigate side effects, and optimize therapeutic effectiveness across a range of disease conditions.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Hydroxychloroquine Market by End-User

• Market Overview
• Hospitals
• Specialty Clinics
• Homecare
• and Others

Global Hydroxychloroquine Market by Distribution Channel

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• and Others

Global Hydroxychloroquine Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apotex (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ranbaxy Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Cadila (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma USA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis Pharmaceuticals Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries USA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals USA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments